Evolving Market Trends In The Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Industry: Emerging Alternatives In DNA Sequencing Pose Challenges To PCR Devices And Reagents Market

The Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Size During the Forecast Period?
The polymerase chain reactions (PCR) devices, reagents, and uses market has experienced significant growth in recent years. It will rise from $6.19 billion in 2024 to $6.51 billion in 2025, showing a compound annual growth rate (CAGR) of 5.0%. This growth can be attributed to the increasing prevalence of infectious diseases, growing demand for clinical diagnostic services, personalized medicine, and the wider use of PCR in research and development.

The polymerase chain reactions (PCR) devices, reagents and uses market is expected to see strong growth, reaching $9.01 billion in 2029 at a CAGR of 8.5%, driven by disease surveillance, cancer diagnostics, and genomics research. Major trends include digital PCR, NGS integration, portable systems, automation, AI applications, and multiplexing.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2485

What Are the High-Growth Segments in the Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market?
The polymerase chain reactions (PCR) devices, reagents and uses market covered in this report is segmented -

1) By Product: Instruments, Reagents, Consumables
2) By Instruments: Standard PCR, RT-PCR, Digital PCR
3) By End User: Pharmaceutical and biotechnology industries, Clinical Diagnostics labs and hospitals, Academics and research organization

Subsegments:
1) By Instruments: Thermal Cyclers, Real-Time PCR Systems, Digital PCR Systems
2) By Reagents: Master Mixes, Primers And Probes, Enzymes, Nucleotides
3) By Consumables: PCR Tubes, PCR Plates, Seals And Films, Pipette Tips

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2485&type=smp

What Key Drivers Are Expected to Influence Future Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Growth?
The polymerase chain reaction (PCR) devices, reagents, and uses market is experiencing growth due to the rising prevalence of infectious diseases. PCR devices are used to detect infectious diseases in clinical laboratories. According to the World Health Organization, around 17 million people die annually from infectious diseases, with 30 new diseases emerging in the last two decades, which increases demand for PCR testing.

Which Companies Hold the Largest Share Across Different Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Segments?
Major companies operating in the polymerase chain reactions (PCR) devices, reagents and uses market include Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Becton Dickinson and Company, Abbott Laboratories, bioMérieux S.A., Agilent Technologies Inc., QIAGEN N.V., Siemens Healthcare GmbH (Siemens AG), Fluidigm Corporation, SYGNIS Pharma AG, Takara Bio Inc., Cepheid, Lontech Laboratories, Eppendorf India Private Limited, GE Healthcare, Kapa Biosystems, Maxim Biomedical Inc., Promega Corporation, RainDance Technologies Inc., Affymetrix Inc., Beckman Coulter Inc., Enzo Life Sciences Inc., Roche Diagnostics GmbH, Merck KGaA, Danaher Corporation, Stilla Technologies, Meridian Bioscience Inc., BioFire Diagnostics LLC, Luminex Corporation, GenMark Diagnostics Inc.

What Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Trends Are Gaining Traction Across Different Segments?
The emergence of alternative techniques is restricting the growth of the polymerase chain reaction (PCR) devices and reagents market. Methods like Next Generation Sequencing and Sanger Sequencing are offering similar or better results, leading to increased competition. For example, studies show that Next Generation Sequencing (NGS) provides more accurate data on allele sequences and mutation detection than PCR, which may limit the growth of PCR devices and reagents.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/polymerase-chain-reactions-devices-reagents-and-uses-global-market-report

What Are the Emerging Geographies for The Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Growth?
The countries covered in the polymerase chain reactions (PCR) devices, reagents and uses market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market?
2. What is the CAGR expected in the Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market?
3. What Are the Key Innovations Transforming the Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Industry?
4. Which Region Is Leading the Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market?

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.